(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are AVENIR TELECOM, PHILIPS KON, and HAVILA SHIPPING.

The three biggest losers today are INTEXA, ORPEA, and ASETEK.

Winners today

1. AVENIR TELECOM (AVT.PA)

16.12% Price Change

Avenir Telecom S.A. designs and distributes mobile phones and mobility accessories in Europe, the Middle East, Africa, Asia, Oceania, and the Americas. The company also provides chargers, cables, memory cards, and screen protectors. It offers its products under the Energizer brand. The company was incorporated in 1989 and is headquartered in Marseille, France.

CAC 40 ended the session with AVENIR TELECOM jumping 16.12% to €0.19 on Monday, after five consecutive sessions in a row of losses. CAC 40 fell 0.04% to €7,573.86, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €102.06.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVENIR TELECOM’s stock is considered to be overbought (>=80).

More news about AVENIR TELECOM.

2. PHILIPS KON (PHIA.AS)

12.4% Price Change

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with PHILIPS KON rising 12.4% to €19.49 on Monday, following the last session’s upward trend. AEX-Index jumped 0.04% to €762.49, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, PHILIPS KON has a trailing twelve months EPS of €-1.84.

Volatility

PHILIPS KON’s last week, last month’s, and last quarter’s current intraday variation average was 1.53%, 0.95%, and 1.61%.

PHILIPS KON’s highest amplitude of average volatility was 1.53% (last week), 1.85% (last month), and 1.61% (last quarter).

More news about PHILIPS KON.

3. HAVILA SHIPPING (HAVI.OL)

10.05% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, Netherlands, Iceland, and the Republic of Chile. The company operates a fleet of 22 vessels, including 5 anchor handling vessels, 13 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING rising 10.05% to €16.42 on Monday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.79% to €1,219.80, after three sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr6.18.

PE Ratio

HAVILA SHIPPING has a trailing twelve months price to earnings ratio of 2.66. Meaning, the purchaser of the share is investing kr2.66 for every norwegian krone of annual earnings.

Yearly Top and Bottom Value

HAVILA SHIPPING’s stock is valued at kr16.42 at 22:40 EST, way under its 52-week high of kr29.50 and way above its 52-week low of kr4.66.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for HAVILA SHIPPING is 435810 which is 48.83% above its average volume of 292818.

More news about HAVILA SHIPPING.

4. TERACT (TRACT.PA)

8.67% Price Change

Teract S.A. operates in retail business in Europe. The company operates through Garden Centre Retailer and Marketer segments. It operates garden centers and pet care shops under the Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brand names. The company also operates in the fresh, local, and organic produce sector under Frais d'Ici and Bio&Co brands with food outlets. It operates 1,597 stores. The company is based in Paris, France.

CAC 40 ended the session with TERACT jumping 8.67% to €6.52 on Monday, after three sequential sessions in a row of losses. CAC 40 dropped 0.04% to €7,573.86, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, TERACT has a trailing twelve months EPS of €0.61.

PE Ratio

TERACT has a trailing twelve months price to earnings ratio of 10.69. Meaning, the purchaser of the share is investing €10.69 for every euro of annual earnings.

Volatility

TERACT’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.58%, a negative 0.01%, and a positive 1.41%.

TERACT’s highest amplitude of average volatility was 2.13% (last week), 1.37% (last month), and 1.41% (last quarter).

More news about TERACT.

5. PCAS (PCA.PA)

8.53% Price Change

PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

CAC 40 ended the session with PCAS rising 8.53% to €7.00 on Monday, after two consecutive sessions in a row of losses. CAC 40 fell 0.04% to €7,573.86, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, PCAS has a trailing twelve months EPS of €-4.91.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCAS’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth grew by 44.4%, now sitting on 226.4M for the twelve trailing months.

More news about PCAS.

6. GEOJUNXION (GOJXN.AS)

8.41% Price Change

GeoJunxion N.V. manufactures and supplies digital maps, premium location content, and location intelligence services worldwide. The company provides location aware content products, including Digital Maps for use in routing, planning, and display services; Geo Location application programming interface (API) that addresses geocoding and time zones covering Europe and North America; and Geo Planning API, which provides time and distance matrices for logistics and resource planning applications, as well as premium location content products, such as Safety Alert Zone that concentrates on road safety by alerting mobility users; Eco Alert Zones, which includes dataset of regulated congestion, emission and restricted traffic zones for use in routing, planning, fleet management, display, real estate applications, and other sectors; and Health Alert Zones that contains COVID-19 related information. It also offers location intelligence services, which includes search and evaluation of location enabled content to enhance existing maps and/or routing applications; creating bespoke datasets; and producing outdoor venue plans for use in events, travel and tourism, real estate applications, last mile navigation and delivery, retail and distribution, and smart city applications, as well as operates GeoAlertsLive application. The company was formerly known as AND International Publishers N.V. GeoJunxion N.V. was founded in 1984 and is headquartered in Capelle aan den IJssel, the Netherlands.

AEX-Index ended the session with GEOJUNXION jumping 8.41% to €1.16 on Monday while AEX-Index rose 0.04% to €762.49.

Earnings Per Share

As for profitability, GEOJUNXION has a trailing twelve months EPS of €-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.3%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GEOJUNXION’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for GEOJUNXION is 4110 which is 9.74% below its average volume of 4554.

More news about GEOJUNXION.

7. AIRTHINGS (AIRX.OL)

7.8% Price Change

Airthings ASA, a hardware-enabled software company, develop products and systems for monitoring indoor air quality, radon, and energy efficiency worldwide. It operates through Consumer, Business, and Professional segments. The Consumer segments sells air quality sensors to private customers through retail and e-commerce. Its Business segment provides air quality solutions to schools, office building, and other commercial buildings. The Professional segment sells measurement solutions, which enables inspectors and certified radon professionals to measure, analyze, and report on buildings; and offers rental of products and calibration services. In addition, it offers digital radon detectors as well as smart indoor air quality monitors and solutions. The company provides its products under the View Plus, Wave Plus, Wave Radon, Wave Mini, House Kit, Hub, Corentium Home, Plus, and Pro brands. Airthings ASA was incorporated in 2008 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with AIRTHINGS rising 7.8% to €2.70 on Monday while Oslo Børs Benchmark Index_GI rose 0.79% to €1,219.80.

Earnings Per Share

As for profitability, AIRTHINGS has a trailing twelve months EPS of kr-0.58.

Volume

Today’s last reported volume for AIRTHINGS is 91093 which is 73.6% below its average volume of 345147.

More news about AIRTHINGS.

8. ABIVAX (ABVX.PA)

7.51% Price Change

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

CAC 40 ended the session with ABIVAX rising 7.51% to €15.74 on Monday while CAC 40 fell 0.04% to €7,573.86.

Earnings Per Share

As for profitability, ABIVAX has a trailing twelve months EPS of €-2.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1286.47%.

Yearly Top and Bottom Value

ABIVAX’s stock is valued at €15.74 at 22:40 EST, way under its 52-week high of €25.50 and way above its 52-week low of €5.60.

More news about ABIVAX.

9. MKB Nedsense (NEDSE.AS)

6.86% Price Change

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense rising 6.86% to €0.11 on Monday, following the last session’s downward trend. AEX-Index rose 0.04% to €762.49, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Volatility

MKB Nedsense’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.50%, a negative 2.06%, and a positive 4.42%.

MKB Nedsense’s highest amplitude of average volatility was 1.50% (last week), 6.44% (last month), and 4.42% (last quarter).

More news about MKB Nedsense.

10. VÅR ENERGI (VAR.OL)

6.57% Price Change

Vår Energi AS, an independent upstream oil and gas company, explores for, develops, and produces hydrocarbons. The company operates four fields on the Norwegian continental shelf, including the Goliat, Marulk, Balder, and Ringhorne and Ringhorne East fields located in the Barents, the Norwegian, and the North Sea, as well as holds ownership interests in 32 producing partner-operated fields on the Norwegian continental shelf. It has reserves of 1,147 million barrels of oil equivalent on the Norwegian continental shelf. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was founded in 1965 and is based in Sandnes, Norway. Vår Energi AS is a subsidiary of Eni International B.V.

Oslo Børs Benchmark Index_GI ended the session with VÅR ENERGI rising 6.57% to €26.91 on Monday while Oslo Børs Benchmark Index_GI rose 0.79% to €1,219.80.

Earnings Per Share

As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr3.61.

PE Ratio

VÅR ENERGI has a trailing twelve months price to earnings ratio of 7.45. Meaning, the purchaser of the share is investing kr7.45 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.67%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VÅR ENERGI’s stock is considered to be overbought (>=80).

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Nov 2, 2022, the estimated forward annual dividend rate is 4.9 and the estimated forward annual dividend yield is 15.93%.

Volatility

VÅR ENERGI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.89%, a positive 0.06%, and a positive 1.49%.

VÅR ENERGI’s highest amplitude of average volatility was 1.09% (last week), 1.46% (last month), and 1.49% (last quarter).

Yearly Top and Bottom Value

VÅR ENERGI’s stock is valued at kr26.91 at 22:40 EST, way below its 52-week high of kr47.19 and way higher than its 52-week low of kr24.36.

More news about VÅR ENERGI.

Losers Today

1. INTEXA (ITXT.PA)

-17.12% Price Change

Intexa S.A. engages in the operation of the photovoltaic installation in Saint-André-de-Cubzac, France. The company was founded in 2011 and is headquartered in Saint-Etienne, France. Intexa S.A. is a subsidiary of Casino Guichard-Perrachon.

CAC 40 ended the session with INTEXA dropping 17.12% to €2.42 on Monday, after five consecutive sessions in a row of losses. CAC 40 slid 0.04% to €7,573.86, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, INTEXA has a trailing twelve months EPS of €0.08.

PE Ratio

INTEXA has a trailing twelve months price to earnings ratio of 30.25. Meaning, the purchaser of the share is investing €30.25 for every euro of annual earnings.

Volume

Today’s last reported volume for INTEXA is 6 which is 50% above its average volume of 4.

More news about INTEXA.

2. ORPEA (ORP.PA)

-12.01% Price Change

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

CAC 40 ended the session with ORPEA sliding 12.01% to €2.87 on Monday while CAC 40 slid 0.04% to €7,573.86.

Earnings Per Share

As for profitability, ORPEA has a trailing twelve months EPS of €-5.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.36%.

Yearly Top and Bottom Value

ORPEA’s stock is valued at €2.87 at 22:40 EST, way below its 52-week high of €35.16 and way higher than its 52-week low of €1.74.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 4.52B for the twelve trailing months.

Volume

Today’s last reported volume for ORPEA is 2112040 which is 24.4% below its average volume of 2793940.

Moving Average

ORPEA’s value is way above its 50-day moving average of €2.53 and way below its 200-day moving average of €10.11.

More news about ORPEA.

3. ASETEK (ASTK.OL)

-11.76% Price Change

Asetek A/S, together with its subsidiaries, engages in the designing, developing, and marketing of liquid cooling solutions in Asia, Europe, and the Americas. The company operates through Liquid cooling, Data center and SimSports segments. Its products are used in personal computers, servers, and data centers to provide improved performance, acoustics, and energy efficiency. It serves original equipment manufacturers, resellers, and channel partners. The company was founded in 1997 and is headquartered in Aalborg, Denmark.

Oslo Børs Benchmark Index_GI ended the session with ASETEK sliding 11.76% to €6.30 on Monday while Oslo Børs Benchmark Index_GI rose 0.79% to €1,219.80.

Earnings Per Share

As for profitability, ASETEK has a trailing twelve months EPS of kr-1.28.

Volatility

ASETEK’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.79%, a positive 6.95%, and a positive 7.70%.

ASETEK’s highest amplitude of average volatility was 8.04% (last week), 16.05% (last month), and 7.70% (last quarter).

More news about ASETEK.

4. BALYO (BALYO.PA)

-8.7% Price Change

Balyo SA designs, develops, and markets material handling robots worldwide. The company offers robotic pallet and reach trucks, tuggers, stackers, counterbalanced stackers, very narrow aisles, and autonomous mobile robots. Its products are used in intelligent pallet detection, barcode scanning, inter-building transport, push button configuration, machine interface, ERP interfacing, and palletizers; and WMS interface and 3D camera applications. The company serves 3PL, automotive, e-commerce, and consumer goods industries. Balyo SA was founded in 2004 and is headquartered in Arcueil, France.

CAC 40 ended the session with BALYO sliding 8.7% to €0.53 on Monday while CAC 40 fell 0.04% to €7,573.86.

Earnings Per Share

As for profitability, BALYO has a trailing twelve months EPS of €-0.18.

Yearly Top and Bottom Value

BALYO’s stock is valued at €0.53 at 22:40 EST, way under its 52-week high of €1.03 and way higher than its 52-week low of €0.38.

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.3%, now sitting on 24.14M for the twelve trailing months.

Volatility

BALYO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.21%, a negative 1.23%, and a positive 4.64%.

BALYO’s highest amplitude of average volatility was 4.69% (last week), 6.67% (last month), and 4.64% (last quarter).

More news about BALYO.

5. GYLDENDAL (GYL.OL)

-7.69% Price Change

Gyldendal ASA, through its subsidiaries publishes and sells books in Norway. It also operates 143 bookstores and an online bookstore. In addition, it publishes dictionaries and encyclopedias; and provides logistics and reporting services to the book industry. The company was founded in 1925 and is based in Oslo, Norway. Gyldendal ASA is a subsidiary of Erik Must AS.

Oslo Børs Benchmark Index_GI ended the session with GYLDENDAL falling 7.69% to €480.00 on Monday, after five consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.79% to €1,219.80, after three sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, GYLDENDAL has a trailing twelve months EPS of kr8.84.

PE Ratio

GYLDENDAL has a trailing twelve months price to earnings ratio of 54.3. Meaning, the purchaser of the share is investing kr54.3 for every norwegian krone of annual earnings.

Volume

Today’s last reported volume for GYLDENDAL is 59 which is 742.85% above its average volume of 7.

More news about GYLDENDAL.

6. GENSIGHT BIOLOGICS (SIGHT.PA)

-6.99% Price Change

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

CAC 40 ended the session with GENSIGHT BIOLOGICS dropping 6.99% to €0.68 on Monday, after two successive sessions in a row of losses. CAC 40 dropped 0.04% to €7,573.86, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.2.

More news about GENSIGHT BIOLOGICS.

7. EASE2PAY NV (EAS2P.AS)

-6.51% Price Change

Ease2pay N.V. provides online payment services and platform in the Netherlands. It offers payment transaction platform, which offers users services to order and pay in one action and parking solutions. The company was formerly known as DOCDATA N.V. and changed its name to Ease2pay N.V. in February 2018. Ease2pay N.V. is headquartered in Waalwijk, the Netherlands. Ease2pay N.V. is a subsidiary of The Internet of Cars V.O.F.

AEX-Index ended the session with EASE2PAY NV sliding 6.51% to €0.80 on Monday, after five successive sessions in a row of losses. AEX-Index jumped 0.04% to €762.49, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, EASE2PAY NV has a trailing twelve months EPS of €-0.09.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.6%.

More news about EASE2PAY NV.

8. SOGN SPAREBANK (SOGN.OL)

-6.49% Price Change

Sogn Sparebank provides various banking products and services in Norway. The company offers savings products; home loans and small loans, as well as loans for cars and other vehicles; credit and other cards; and mobile and online banking services. It also provides bank guarantees, construction loans, overdraft, and business loans, as well as leasing and securities trading services. In addition, the company offers home and leisure, animals, damage, car, liability, work machine, data attack, farm building, operating equipment and crop, property damage, health, homeowners, agriculture, craftsman, commercial vehicle, business, and personnel insurance products. Sogn Sparebank was founded in 1846 and is based in Årdalstangen, Norway.

Oslo Børs Benchmark Index_GI ended the session with SOGN SPAREBANK sliding 6.49% to €173.00 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.79% to €1,219.80, after three successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, SOGN SPAREBANK has a trailing twelve months EPS of kr15.63.

PE Ratio

SOGN SPAREBANK has a trailing twelve months price to earnings ratio of 11.07. Meaning, the purchaser of the share is investing kr11.07 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.56%.

More news about SOGN SPAREBANK.

9. FOUNTAIN (FOU.BR)

-6.4% Price Change

Fountain S.A. engages in the sale, rental, and provision of machines for cold and hot drinks made from freeze-dried or grain products in Europe. It provides coffee and cartridge machines, and other beverages machines. The company offers its products through independent distributors. Fountain S.A. was founded in 1972 and is based in Braine-l'Alleud, Belgium.

BEL 20 ended the session with FOUNTAIN sliding 6.4% to €1.17 on Monday, after four sequential sessions in a row of losses. BEL 20 rose 0.16% to €3,832.59, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, FOUNTAIN has a trailing twelve months EPS of €-0.18.

Volume

Today’s last reported volume for FOUNTAIN is 300 which is 80.72% above its average volume of 166.

More news about FOUNTAIN.

10. KID (KID.OL)

-5.56% Price Change

Kid ASA, together with its subsidiaries, operates as a home textile retailer in Norway, Sweden, Finland, and Estonia. It designs, sources, markets, and sells a range of home and interior products, including textiles, curtains, bed linens, home accessories, decorations, furniture, and other interior products through retail stores and online platforms. The company provides its products under the Kid, Hemtex, Dekosol, Nordun, and Premium Collection brands. It also offers logistics services. The company was formerly known as Nordisk Tekstil Holding AS and changed its name to Kid ASA. Kid ASA was founded in 1937 and is headquartered in Lier, Norway.

Oslo Børs Benchmark Index_GI ended the session with KID sliding 5.56% to €84.90 on Monday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.79% to €1,219.80, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, KID has a trailing twelve months EPS of kr6.27.

PE Ratio

KID has a trailing twelve months price to earnings ratio of 13.54. Meaning, the purchaser of the share is investing kr13.54 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.66%.

More news about KID.

Stay up to date with our winners and losers daily report